PostDoc in therapeutic tumor biology

In der aktuellen Covid-19 Situation laufen die Rekrutierungen weiter. Es kann dabei allerdings zu Verzögerungen kommen. Vielen Dank für Ihr Verständnis.

100%, fixed-term

The Center for Radiopharmaceutical Sciences – a joint endeavor of ETH Zurich and the Paul Scherrer Institute – develops new innovative radiolabeled pharmaceuticals for diagnosis and therapy. The molecular effect from therapeutic radiopharmaceutical is of high interest and an innovative growing field in which we will invest.

Project background

We are interested in developing radioimmunotherapy for T-cell lymphomas and understanding its effects on the cellular network. Therefore, we will use state-of-the-art omics analyses to investigate the responses of lymphoma cells to targeted radionuclide therapy at the molecular level. Together with the clinical partner at the University Hospital of Bern (Inselspital, Dept. of Clinical Oncology and University of Bern, Institute of Pathology) we will establish clinically relevant lymphoma in vivo models. Candidates will have full access to the entire infrastructure of ETH and PSI to achieve the goals of this project.

Job description

You will be involved in the development of innovative approaches for the treatment of cancer with radionuclides, focusing on their effects on lymphoma cells at the molecular level. We are seeking candidates with a PhD in tumor/molecular biology and/or other relevant fields with an excellent scientific track record. The successful candidate will be responsible for the design and conduct of preclinical studies and regular reporting of progress including scientific presentations and publications. Experimental work will be performed at the Paul Scherrer Institute, ETH Zurich and Inselspital in Bern.

Your profile

• PhD in tumor biology, molecular biology, cancer signaling or relevant fields
• Experience in cancer mouse models – lymphoma model would be an advantage
• Knowledge and understanding of omics technologies (e.g. Proteomics) is a plus
• Readiness to work with radionuclides and mouse animal models is essential
• Strong motivation to work in an ambitious interdisciplinary environment
• High flexibility and strong communication and presentation skills

We offer

The position offers the unique opportunity to be part of a multidisciplinary team to shape the development of innovative cancer therapies.

ETH Zurich

ETH Zurich is one of the world’s leading universities specialising in science and technology. We are renowned for our excellent education, cutting-edge fundamental research and direct transfer of new knowledge into society. Over 30,000 people from more than 120 countries find our university to be a place that promotes independent thinking and an environment that inspires excellence. Located in the heart of Europe, yet forging connections all over the world, we work together to develop solutions for the global challenges of today and tomorrow.

Working, teaching and research at ETH Zurich